Examining the Interplay Between Diabetic Foot Ulcers and Social Factors in Health

Addressing the Intersection of Diabetic Foot Ulcers and Social Determinants of Health

Examining the Interplay Between Diabetic Foot Ulcers and Social Factors in Health
Diabetic Foot Ulcers and Social Factors in Health

In the ongoing battle against diabetes, individuals face the daily challenge of managing comorbidities and raising awareness. While heart failure and chronic kidney disease often take the spotlight due to their immediate threats to mortality risk and quality of life, diabetic foot ulcers remain a significant concern. Despite progress in reducing amputation risks, foot ulcers continue to impact the well-being and survival of patients. The lifetime risk for individuals with type 2 diabetes to develop foot ulcers ranges from 19% to 34%, with millions worldwide affected each year. Social determinants of health play a role in exacerbating or alleviating this risk, underscoring the need for action.

During the 83rd Scientific Sessions of the American Diabetes Association (ADA 2023), experts engaged in discussions to address this issue. Diana Isaacs, PharmD, and Natalie Bellini, DNP, hosted several special episodes of The Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives. Among their guests was Gary Rothenberg, DPM, an assistant professor and pediatrician specializing in internal medicine and director of Medical Affairs at Podimetrics. Podimetrics, a technology company based in Boston, Massachusetts, utilizes artificial intelligence and data to bridge the gap in care for patients.

During his appearance on the show, Rothenberg emphasized the importance of educating both patients and healthcare providers about the risks associated with foot ulcers in people with diabetes. He also highlighted how social determinants of health influence the likelihood of developing foot ulcers. In addition to his participation in the Diabetes Dialogue, Rothenberg led a session at ADA 2023 that explored the application of artificial intelligence in diabetic foot disease.

Next Article